| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 8 |
| 1 | TACROLIMUS | 8 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 3 | TACROLIMUS OINTMENT 0.1% | 8 |
| 4 | MYCOPHENOLATE MOFETIL | 6 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 6 |
| 6 | ALPHA-1-PROTEINASE INHIBITOR (HUMAN) | 4 |
| 7 | ALPHA-1-PROTEINASE INHIBITOR HUMAN | 4 |
| 8 | SECUKINUMAB | 2 |
| 9 | ALBUTEROL SULFATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 1 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 1 | 0.0002 |
| 2 | HYOSCYAMINE SULFATE | 1 | 0.0001 |
| 3 | DASATINIB | 1 | 0.0001 |
| 4 | MUPIROCIN CALCIUM | 1 | 0.0001 |
| 5 | TACROLIMUS OINTMENT 0.1% | 8 | 0.0001 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 | 0.0001 |
| 7 | TACROLIMUS | 8 | 0.0001 |
| 8 | MYCOPHENILIC ACID | 1 | 0.0000 |
| 9 | MYCOPHENOLATE MOFETIL | 6 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | General Anesthetic [EPC] | 1 | 0.0000 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |